Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75 years old

New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety

(2011) Himisha Beltran et al.   EUROPEAN UROLOGY

Feasibility of Tri-Weekly Docetaxel-Based Chemotherapy for Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer

(2011) Natsuki Takaha et al.   UROLOGIA INTERNATIONALIS

Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology

(2010) Jean-Pierre Droz et al.   BJU INTERNATIONAL

Recent Advances in Understanding Hormonal Therapy Resistant Prostate Cancer

(2010) K.V. Donkena et al.   CURRENT CANCER DRUG TARGETS

CYP3A4*16 and CYP3A4*18 Alleles Found in East Asians Exhibit Differential Catalytic Activities for Seven CYP3A4 Substrate Drugs

(2010) K. Maekawa et al.   DRUG METABOLISM AND DISPOSITION

Cancer Incidence and Incidence Rates in Japan in 2005: Based on Data from 12 Population-based Cancer Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project

(2010) T. Matsuda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Genetic Alterations at 13q14 May Correlate with Differences in the Biological Behavior of Prostate Cancer between Japanese and Caucasian Men

(2010) Taku Misumi et al.   UROLOGIA INTERNATIONALIS

The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival

(2009) Andrew J. Armstrong et al.   EUROPEAN JOURNAL OF CANCER

Ethnic differences in drug metabolism and toxicity from chemotherapy

(2009) Viet Hong Phan et al.   Expert Opinion on Drug Metabolism & Toxicology

Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer

(2009) Akihiro Matsumoto et al.   INTERNATIONAL JOURNAL OF UROLOGY

Docetaxel in Combination with Prednisolone for Hormone Refractory Prostate Cancer

(2009) H. Ide et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer

(2008) Antoine Italiano et al.   EUROPEAN UROLOGY

Docetaxel Plus Prednisolone for the Treatment of Metastatic Hormone-refractory Prostate Cancer: A Multicenter Phase II Trial in Japan

(2008) S. Naito et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Prostate-Specific Antigen Kinetics in Screen-Detected Prostate Cancer in Japan

(2008) Hiroyuki Takechi et al.   UROLOGY